Company intelligence / Profile preview

SpinChip Diagnostics

Ownership: Private
Employees: ~50
Development stage: Preclinical

Overview

The company has developed a proprietary point-of-care immunoassay diagnostics platform capable of delivering lab-quality results from whole blood samples within ten minutes. Initial clinical focus includes high-sensitivity cardiac troponin assays for rapid and accurate myocardial infarction diagnosis at the point of care. The technology aims to reduce emergency department stays and healthcare costs by enabling faster clinical decisions.

No detailed published clinical trial results are available in the search results.

bioMérieux acquired the company in January 2025 after previously holding a minority stake.

Therapeutic areas: OtherCardiovascular
Modalities: DeviceDiagnostic platform (In vitro diagnostics)Immunoassay diagnostics platform
Industry: Protein Biomarker Diagnostics

Partnerships

bioMérieux (minority investor since March 2024; acquirer as of January 2025)

Beyond the preview

Go deeper on SpinChip Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SpinChip Diagnostics.

Explore the full profile